Cathie's Ark Logo

Cathie's Ark

Ark Invest Fund Holdings
Twist Bioscience Corp Logo

ARKG Holdings of Twist Bioscience (TWST) - Updated Daily

Earnings Date: Thursday, Feb 4th
Fund Weight
February 26, 2021SELL514040.0666%ARKG
February 25, 2021SELL412020.0533%ARKG
February 24, 2021SELL1044490.1278%ARKG
February 22, 2021SELL307810.0354%ARKG
February 19, 2021SELL316660.04%ARKG

Key Statistics

🕵🏼Found In🏷Last Price
⚖️Weighting🧢Market Cap
🏋🏿‍♂️Weight Rank In ARKG🧮Price to Sales
🏋️‍♀️Weight Rank Across All Funds🐻Short Percent
🎫Ark Ownership Percent🌏Country
6.46%🇺🇸United States
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by 'writing' DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
📅 Next Earnings Date
February 4th 2021

Research Notes and Commentary for TWST

No Research Notes Found for TWST